Category: Include on Menu
-
Sandisk shares slide as cautious guidance overshadows strong AI-driven growth
Sandisk (NASDAQ:SNDK) shares fell in premarket trading on Thursday after the flash memory manufacturer issued first-quarter guidance that failed to meet investors’ elevated expectations, despite another quarter of exceptional growth fuelled by artificial intelligence demand. The company forecast fiscal first-quarter 2027 revenue of between $10.3 billion and $10.8 billion, broadly in line with market forecasts…
-
AppLovin shares tumble as revenue miss and cautious outlook outweigh earnings beat
AppLovin Corporation (NASDAQ:APP) shares plunged more than 14% in premarket trading on Thursday after the software company delivered quarterly earnings that exceeded expectations but failed to satisfy investors on revenue growth and forward guidance. For the second quarter ended 30 June, AppLovin reported adjusted earnings per share of $3.76, narrowly ahead of the consensus estimate…
-
Moderna secures FDA approval for its first mRNA influenza vaccine
Moderna (NASDAQ:MRNA) announced on Thursday that the U.S. Food and Drug Administration has approved its influenza vaccine, mFLUSIVA, for adults aged 50 and over. The decision marks the company’s first mRNA-based flu vaccine and the fourth product from Moderna to receive FDA approval. The biotechnology group expects to begin distributing mFLUSIVA to selected U.S. retailers…
-
Oil steadies after sharp weekly decline as Hormuz developments offset by supply concerns
Oil prices traded with little direction on Thursday, remaining close to their recent lows as markets balanced tentative progress on shipping through the Strait of Hormuz against ongoing geopolitical uncertainty and an unexpected increase in U.S. crude inventories. At 02:55 ET (06:55 GMT), October Brent crude futures edged 0.3% higher to $79.71 per barrel, while…
-
Gold holds near seven-week peak as Hormuz hopes offset Fed tightening concerns
Gold prices eased from earlier highs on Thursday but continued to trade close to their strongest level in seven weeks, as growing optimism over a possible agreement to reopen the Strait of Hormuz helped ease inflation expectations and reduced concerns that the Federal Reserve may need to tighten monetary policy further. At 00:57 ET (04:57…
-
US futures steady as Iran negotiations, earnings and economic data dominate attention: Dow Jones, S&P, Nasdaq, Wall Street
U.S. stock index futures traded with little direction on Thursday as investors monitored diplomatic developments involving Iran, assessed another round of corporate earnings and looked ahead to key labour market data due later this week. At 01:17 ET (05:17 GMT), Dow Jones futures were up 122 points, or 0.2%, while S&P 500 futures also gained…
-
Dow Closes at Fresh Record as Healthcare Gains Offset an AI-Led Tech Retreat
U.S. stocks split down the middle on Wednesday as a rotation out of high-flying technology names met strength in healthcare and consumer stocks. The Dow Jones Industrial Average pushed to another all-time closing high, but the tech-heavy Nasdaq Composite slipped as chipmakers came under renewed pressure. The story of the day was earnings season: strong…
-
Eli Lilly stock jumps as GLP-1 sales widen Novo lead
Eli Lilly shares jumped after Mounjaro and Zepbound drove a 48 per cent revenue increase, widening its lead over Novo Nordisk.
-
Markets in Motion: economic outlook supports broader sector rotation
Bruce Campbell examines the copper-gold ratio, insider activity and improving momentum across financials, industrials and other market sectors.
-
SpaceX Delivers Strong Q2 Results as Investors Look for a Rebound
Investors are closely watching SpaceX following the release of its highly anticipated second-quarter earnings report, the company’s first since becoming publicly traded. The results come at a pivotal moment for the aerospace and technology giant. Shares have fallen nearly 25% from their US$150 IPO price last month and remain approximately 50% below their all-time high…